Eads & Heald Wealth Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.64M | Buy |
2,924
+101
| +4% | +$64.8K | 0.82% | 52 |
|
|
2025
Q4 | $1.91M | Sell |
2,823
-26
| -0.9% | -$17.7K | 0.92% | 44 |
|
|
2025
Q3 | $1.82M | Buy |
2,849
+204
| +8% | +$124K | 0.87% | 48 |
|
|
2025
Q2 | $1.42M | Buy |
2,645
+257
| +11% | +$123K | 0.7% | 59 |
|
|
2025
Q1 | $1M | Buy |
2,388
+5
| +0.2% | +$2.17K | 0.51% | 81 |
|
|
2024
Q4 | $985K | Sell |
2,383
-236
| -9% | -$104K | 0.48% | 85 |
|
|
2024
Q3 | $1.32M | Sell |
2,619
-67
| -2% | -$32.5K | 0.63% | 75 |
|
|
2024
Q2 | $1.31M | Buy |
2,686
+22
| +0.8% | +$11K | 0.63% | 71 |
|
|
2024
Q1 | $1.44M | Sell |
2,664
-143
| -5% | -$78.1K | 0.67% | 74 |
|
|
2023
Q4 | $1.56M | Sell |
2,807
-50
| -2% | -$23.5K | 0.75% | 65 |
|
|
2023
Q3 | $1.25M | Sell |
2,857
-70
| -2% | -$34.9K | 0.66% | 75 |
|
|
2023
Q2 | $1.47M | Sell |
2,927
-150
| -5% | -$71.9K | 0.72% | 69 |
|
|
2023
Q1 | $1.54M | Sell |
3,077
-227
| -7% | -$109K | 0.76% | 64 |
|
|
2022
Q4 | $1.35M | Sell |
3,304
-23
| -0.7% | -$8.93K | 0.69% | 68 |
|
|
2022
Q3 | $1.08M | Sell |
3,327
-36
| -1% | -$13.2K | 0.61% | 75 |
|
|
2022
Q2 | $1.18M | Buy |
3,363
+698
| +26% | +$285K | 0.64% | 72 |
|
|
2022
Q1 | $1.46M | Sell |
2,665
-7
| -0.3% | -$3.68K | 0.68% | 70 |
|
|
2021
Q4 | $1.76M | Sell |
2,672
-11
| -0.4% | -$6.91K | 0.76% | 62 |
|
|
2021
Q3 | $1.67M | Sell |
2,683
-277
| -9% | -$186K | 0.81% | 59 |
|
|
2021
Q2 | $1.87M | Sell |
2,960
-313
| -10% | -$173K | 0.91% | 52 |
|
|
2021
Q1 | $1.6M | Sell |
3,273
-236
| -7% | -$118K | 0.82% | 59 |
|
|
2020
Q4 | $1.75M | Sell |
3,509
-602
| -15% | -$269K | 0.95% | 48 |
|
|
2020
Q3 | $1.62M | Sell |
4,111
-994
| -19% | -$367K | 0.97% | 48 |
|
|
2020
Q2 | $1.69M | Sell |
5,105
-589
| -10% | -$171K | 1.02% | 46 |
|
|
2020
Q1 | $1.38M | Sell |
5,694
-177
| -3% | -$46.2K | 0.97% | 46 |
|
|
2019
Q4 | $1.53M | Buy |
5,871
+76
| +1% | +$20K | 0.81% | 60 |
|
|
2019
Q3 | $1.58M | Sell |
5,795
-34
| -0.6% | -$9.46K | 0.88% | 57 |
|
|
2019
Q2 | $1.6M | Sell |
5,829
-507
| -8% | -$125K | 0.91% | 54 |
|
|
2019
Q1 | $1.42M | Buy |
6,336
+35
| +0.6% | +$7.22K | 0.82% | 61 |
|
|
2018
Q4 | $1.17M | Sell |
6,301
-39
| -0.6% | -$8K | 0.78% | 61 |
|
|
2018
Q3 | $1.58M | Sell |
6,340
-991
| -14% | -$241K | 0.91% | 54 |
|
|
2018
Q2 | $1.6M | Buy |
7,331
+393
| +6% | +$81K | 0.98% | 47 |
|
|
2018
Q1 | $1.33M | Sell |
6,938
-535
| -7% | -$98.7K | 0.84% | 55 |
|
|
2017
Q4 | $1.17M | Buy |
7,473
+30
| +0.4% | +$4.72K | 0.69% | 73 |
|
|
2017
Q3 | $1.16M | Sell |
7,443
-11
| -0.1% | -$1.74K | 0.72% | 70 |
|
|
2017
Q2 | $1.2M | Buy |
7,454
+284
| +4% | +$46.1K | 0.77% | 67 |
|
|
2017
Q1 | $1.11M | Sell |
7,170
-1,093
| -13% | -$151K | 0.71% | 71 |
|
|
2016
Q4 | $969K | Sell |
8,263
-92
| -1% | -$10.5K | 0.66% | 73 |
|
|
2016
Q3 | $942K | Buy |
8,355
+774
| +10% | +$81.6K | 0.65% | 73 |
|
|
2016
Q2 | $704K | Sell |
7,581
-773
| -9% | -$66.4K | 0.48% | 87 |
|
|
2016
Q1 | $654K | Sell |
8,354
-170
| -2% | -$12.2K | 0.45% | 90 |
|
|
2015
Q4 | $622K | Sell |
8,524
-30
| -0.4% | -$2.14K | 0.43% | 93 |
|
|
2015
Q3 | $635K | Sell |
8,554
-640
| -7% | -$45.8K | 0.45% | 90 |
|
|
2015
Q2 | $590K | Buy |
9,194
+74
| +0.8% | +$5.12K | 0.39% | 101 |
|
|
2015
Q1 | $704K | Buy |
9,120
+10
| +0.1% | +$778 | 0.45% | 89 |
|
|
2014
Q4 | $675K | Buy |
9,110
+1,600
| +21% | +$112K | 0.43% | 94 |
|
|
2014
Q3 | $442K | Sell |
7,510
-940
| -11% | -$59.4K | 0.3% | 104 |
|
|
2014
Q2 | $564K | Buy |
+8,450
| New | +$537K | 0.37% | 97 |
|
Other funds holding IDXX
VCM
VPM
Eads & Heald Wealth Management's IDXX Position: Q1 2026 in Review
Eads & Heald Wealth Management increased its Idexx Laboratories (IDXX) stake by 3.6% in Q1 2026, buying an estimated $64.8K and bringing the position to 2,924 shares worth $1.64M. The position accounts for 0.82% of the portfolio, ranked #52.
Eads & Heald Wealth Management first reported a position in IDXX in Q2 2014 and has held it in 48 quarters since. The position peaked at $1.91M in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Eads & Heald Wealth Management held 2,924 shares of Idexx Laboratories worth $1.64M as of Q1 2026.
- Eads & Heald Wealth Management bought 101 Idexx Laboratories shares in Q1 2026, an estimated $64.8K.
- Idexx Laboratories made up 0.82% of Eads & Heald Wealth Management's portfolio in Q1 2026, its #52 holding.
- Eads & Heald Wealth Management first reported a position in Idexx Laboratories in Q2 2014 and has held it in 48 quarters since.
- Eads & Heald Wealth Management's Idexx Laboratories position peaked at $1.91M in Q4 2025.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Eads & Heald Wealth Management's 13F filing for Q1 2026, filed 29 Apr 2026.